Back to top
more

ABM Industries (ABM)

(Delayed Data from NYSE)

$57.73 USD

57.73
338,875

+0.77 (1.35%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $57.77 +0.04 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 13% (33 out of 250)

Industry: Building Products - Maintenance Service

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Is ABM Industries (ABM) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Business Services Stocks Lagging Booz Allen Hamilton (BAH) This Year?

by Zacks Equity Research

Here is how Booz Allen Hamilton (BAH) and ABM Industries (ABM) have performed compared to their sector so far this year.

Implied Volatility Surging for ABM Industries (ABM) Stock Options

by Zacks Equity Research

Investors need to pay close attention to ABM Industries (ABM) stock based on the movements in the options market lately.

Should Value Investors Buy ABM Industries (ABM) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Business Services Stocks Lagging Charles River Associates (CRAI) This Year?

by Zacks Equity Research

Here is how CRA International (CRAI) and ABM Industries (ABM) have performed compared to their sector so far this year.

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

by Zacks Equity Research

RVTY's continued focus on innovations and a strong product portfolio raise optimism about the stock.

ABM Industries Stock Rises 16% in Six Months: Here's Why

by Zacks Equity Research

ABM's resilient services and sustainability focus have driven strong earnings, boosted by key acquisitions and demand in essential sectors.

AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise

by Zacks Equity Research

AngioDynamics (ANGO) delivers decent top-line results on a pro-forma basis in first-quarter fiscal 2025, driven by strength in the Med Tech business.

Reasons to Add Avanos Medical Stock in Your Portfolio Now

by Zacks Equity Research

AVNS's strong product line and focus on R&D raise optimism about the stock.

Reasons to Retain GE HealthCare Stock in Your Portfolio Now

by Zacks Equity Research

GEHC's continued focus on innovations, acquisitions and partnerships raise optimism about the stock.

SYK Stock May Gain From Completion of Vertos Medical Acquisition

by Zacks Equity Research

Stryker completes the acquisition of Vertos Medical to expand its interventional pain management solutions.

Is HealthEquity Stock a Buy Now Amid Strength in HSAs?

by Zacks Equity Research

HQY's strong quarterly results and solid top-line growth raise optimism about the stock.

ITGR Shares Gain on the Divestiture of Its Non-Medical Business Line

by Zacks Equity Research

Integer Holdings announces to divest its Electrochem business to Ultralife for $50 million in cash.

Baxter Shares May Gain on the Launch of Its Latest Vest APX System

by Zacks Equity Research

BAX launches its next-generation airway clearance system, The Vest APX System, for chronic lung conditions.

PDCO Shares Gain Following New Deals to Boost Animal Health Business

by Zacks Equity Research

Patterson Companies announces to invest in two separate businesses to boost its animal health business.

Here's Why you Should Retain Nevro Stock in Your Portfolio Now

by Zacks Equity Research

Strength in NVRO's Senza Platform and business diversification plans raises optimism about the stock.

Accenture's Q4 Earnings & Revenues Beat Estimates, Increase Y/Y

by Zacks Equity Research

ACN's fourth-quarter fiscal 2024 earnings and revenues increase year over year.

NVRO Stock May Gain on the FDA Approval of Its HFX AdaptivAI Platform

by Zacks Equity Research

Nevro announces the FDA approval and limited market release of HFX iQ with HFX AdaptivAI.

Reasons to Retain Veeva Systems Stock in Your Portfolio Now

by Zacks Equity Research

VEEV's robust product portfolio raises optimism about the stock. However, stiff competition and escalating costs are concerning.

ITGR Shares May Gain on the Completion of Irish Facility Expansions

by Zacks Equity Research

Integer Holdings announces the completion of its Irish facility expansions in Galway and New Ross to support growth.

Stryker Shares May Gain on the Completion of the Acquisition of NICO

by Zacks Equity Research

SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH.

SNN Stock Rises on the Completion of First Case With CATALYSTEM System

by Zacks Equity Research

Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.

Here's Why Hold Strategy is Apt for ABM Industries Stock Now

by Zacks Equity Research

ABM has consistently demonstrated its commitment to rewarding shareholders through dividends and share buybacks.

Here's Why You Should Retain McKesson Stock in Your Portfolio Now

by Zacks Equity Research

MCK's strategic collaborations and strength in Biologics raise optimism about the stock.

GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool

by Zacks Equity Research

GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.